Revolution Medicines (RVMD) Net Margin (QoQ) (2019 - 2023)

Revolution Medicines (RVMD) Net Margin (QoQ) (2019 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2023 -159,967.00
Mar 31, 2023 -60,215.00
Dec 31, 2022 181,628.00
Sep 30, 2022 -151,342.00
Jun 30, 2022 8,913.00
Mar 31, 2022 -20,389.00
Dec 31, 2021 425,153.00
Sep 30, 2021 -429,906.00
Jun 30, 2021 -14,235.00
Mar 31, 2021 2,391.00
Dec 31, 2020 -17,586.00
Sep 30, 2020 5,647.00
Jun 30, 2020 -8,320.00
Mar 31, 2020 -3,236.00
Dec 31, 2019 -1,946.00
Sep 30, 2019 -2,912.00
Jun 30, 2019 -1,006.00